Mimetogen Pharmaceuticals is a late stage clinical biotechnology company focused on developing synthetic neurotrophin mimetics for treating ocular surface diseases with unmet medical needs. The company is developing its lead compound, tavilermide, for dry eye disease.

Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals is a late stage clinical biotechnology company focused on developing synthetic neurotrophin mimetics for treating ocular surface diseases with high unmet medical needs. Self-described efforts include advancing tavilermide for dry eye disease and developing treatments for ophthalmologic degenerative diseases.

Mimetogen Pharmaceuticals Inc. | 74 followers on LinkedIn. 

MIME

COM:MIMETOGEN

Mimetogen Pharmaceuticals